Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SNF 9007

Known as: SNF-9007, SNF9007 
 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

CholecystokininPeptide Fragments
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Cholecystokinin-Induced Antinociception is Not Blocked by CCK-A or CCK-B Receptor Antagonists
To determine the relative importance of CCK-A, CCK-B, and opioid receptors in mediating the antinociceptive actions of… Expand
1996
1996
The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe…
The cholecystokinin (26-33) [CCK (26-33)] octapeptide analog Asp-Tyr-D-Phe-Gly-Trp(N-Me)-Nle-Asp-Phe-NH2 (SNF 9007) is a potent… Expand
1994
1994
SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Intracerebroventricular administration of the synthetic cholecystokinin analog SNF9007 (Asp-Tyr-D-Phe-Gly-Trp-[NMe]-Nle-Asp-Phe… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE